| Articles Reviewed |
| 1: | Neil C Henderson et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. 2008 |
| 2: | Lanying Song et al. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. 2007 |
| 3: | Yasuko Yamamura et al. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. 2006 |
| 4: | Kyung Song et al. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. 2006 |
| 5: | Takayuki Furumatsu et al. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. 2005 |
| 6: | Xiao Liang Zhang et al. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. 2005 |
| 7: | Taihao Quan et al. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts. 2005 |
| 8: | Constance E Runyan et al. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. 2005 |
| 9: | Che-Chang Chang et al. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. 2005 |
| 10: | Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005 |
| 11: | Yoshihide Asano et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. 2004 |
| 12: | Michael B Major et al. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta. 2004 |
| 13: | Byung-Chul Kim et al. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. 2004 |
| 14: | Gabriella Lakos et al. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. 2004 |
| 15: | Annie Lacerte et al. Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. 2004 |
| 16: | Lisa Choy et al. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. 2003 |
| 17: | Kiyoshi Higashi et al. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. 2003 |
| 18: | Celine Prunier et al. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. 2003 |
| 19: | Biao Hu et al. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. 2003 |
| 20: | Dirk Haller et al. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. 2003 |
| 21: | Pedro Soto et al. SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells. 2003 |
| 22: | Christos Chadjichristos et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. 2002 |
| 23: | Joanna Czuwara-Ladykowska et al. Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. 2002 |
| 24: | Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002 |
| 25: | Chunming Dong et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. 2002 |
| 26: | Susan Fanayan et al. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. 2002 |
| 27: | Tilman Sánchez-Elsner et al. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. 2002 |
| 28: | Lilly Y W Bourguignon et al. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. 2002 |
| 29: | M Furuhashi et al. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. 2001 |
| 30: | S L Stroschein et al. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. 2001 |